Recruiting subjects for acute stroke trials: a meta-analysis
JS Elkins, T Khatabi, L Fung, J Rootenberg… - Stroke, 2006 - Am Heart Assoc
Background and Purpose—Recruitment rate is a major determinant of the duration, cost,
and feasibility of acute stroke trials. Methods—We performed a meta-analysis of all …
and feasibility of acute stroke trials. Methods—We performed a meta-analysis of all …
Adverse drug reactions: part II.
JM Wooten - Southern medical journal, 2010 - europepmc.org
Pharmacovigilance is the process of identifying, monitoring, and effectively reducing
adverse drug reactions. Adverse drug reactions (ADRs) are an important consideration …
adverse drug reactions. Adverse drug reactions (ADRs) are an important consideration …
[HTML][HTML] Can current electronic systems meet drug safety and effectiveness requirements?
A Holbrook, P Grootendorst, D Willison… - AMIA Annual …, 2005 - ncbi.nlm.nih.gov
Background Every health policy jurisdiction is endeavoring to enhance its ability to evaluate
drug effectiveness, safety and cost in the real world (pharmacosurveillance). Methods A …
drug effectiveness, safety and cost in the real world (pharmacosurveillance). Methods A …
The best type of trial
JAC Delaney - CMAJ, 2004 - Can Med Assoc
1. Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL. Efficacy and
safety of antidepressants for children and adolescents. BMJ 2004; 328: 879-83. 2 …
safety of antidepressants for children and adolescents. BMJ 2004; 328: 879-83. 2 …
Evaluation of data sources to support pharmacosurveillance
AM Holbrook - 2004 - policycommons.net
Holbrook, AM Evaluation of Data Sources to Support Pharmacosurveillance 8 4. FULL
REPORT The “Evaluation Of Data Sources To Support Pharmacosurveillance” project …
REPORT The “Evaluation Of Data Sources To Support Pharmacosurveillance” project …
SSRI treatment for under-18s
EJ Garland - CMAJ, 2004 - Can Med Assoc
1. Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL. Efficacy and
safety of antidepressants for children and adolescents. BMJ 2004; 328: 879-83. 2 …
safety of antidepressants for children and adolescents. BMJ 2004; 328: 879-83. 2 …
The best type of trial
MR Pijak, F Gazdik, S Hrusovsky - CMAJ, 2004 - Can Med Assoc
1. Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL. Efficacy and
safety of antidepressants for children and adolescents. BMJ 2004; 328: 879-83. 2 …
safety of antidepressants for children and adolescents. BMJ 2004; 328: 879-83. 2 …
[PDF][PDF] Clinical Trials in Perspective
WH Eaglstein, LC Parish - WITH GENTLE EFFICACY1, 2010 - academia.edu
CONCLUSIONS All of the above is not aimed toward the conclusion that RCTs are without
value, especially concerning regulatory approval. he regulatory requirement for evidence …
value, especially concerning regulatory approval. he regulatory requirement for evidence …
SSRI treatment for under-18s
A Herxheimer, B Mintzes - CMAJ, 2004 - Can Med Assoc
Let me see if I've got this straight. In-dustry bias in reporting the results of trials of selective
serotonin reuptake inhibitors (SSRIs) is probable, 1 although an employee of a multinational …
serotonin reuptake inhibitors (SSRIs) is probable, 1 although an employee of a multinational …
[PDF][PDF] and interpersonal therapy4 need to be made more available.
A Herxheimer, B Mintzes - CMAJ, 2004 - Citeseer
1. Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL. Efficacy and
safety of antidepressants for children and adolescents. BMJ 2004; 328: 879-83. 2 …
safety of antidepressants for children and adolescents. BMJ 2004; 328: 879-83. 2 …